We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Eli Lilly以21亿美元收购拥有肥胖症药物的Maze Therapeutics。条款、隐藏风险及投资者收益详解。了解更多。
